A Single-Dose Influenza A (H5N1) Vaccine Safe and Immunogenic in Adult and Elderly Patients: an Approach to Pandemic Vaccine Development

Eitemau Tebyg

• Yearly licensing studies from 1997 to 2007 of the inactivated whole virus seasonal influenza vaccine fluval – a useful approach to pandemic vaccine development even in less well developed countries?
  gan: Vajo, Zoltan, et al.
  Cyhoeddwyd: (2008)
• Inactivated Whole Virus Influenza A (H5N1) Vaccine
  gan: Vajo, Zoltan, et al.
  Cyhoeddwyd: (2007)
• A Reduced-Dose Seasonal Trivalent Influenza Vaccine Is Safe and Immunogenic in Adult and Elderly Patients in a Randomized Controlled Trial
  gan: Vajo, Zoltan, et al.
  Cyhoeddwyd: (2012)
• Cross-Reactive Immunity to Clade 2 Strains of Influenza Virus A Subtype H5N1 Induced in Adults and Elderly Patients by Fluval, a Prototype Pandemic Influenza Virus Vaccine Derived by Reverse Genetics, Formulated with a Phosphate Adjuvant, and Directed to Clade 1 Strains
  gan: Fazekas, György, et al.
  Cyhoeddwyd: (2009)
• Protection of Chinese painted quails (Coturnix chinensis) against a highly pathogenic H5N1 avian influenza virus strain after vaccination
  gan: Sarkadi, Julia, et al.
  Cyhoeddwyd: (2013)